New things are always developing at Children's Mercy Hospitals and Clinics. This page is a resource for updates about new research studies, clinical breakthroughs and other information about our Individualized Pediatric Personalized Therapeutics program.
Taking the Lead in Pediatric Personalized Medicine
As home to the largest pediatric clinical pharmacology program in North America, Children's Mercy has led the study of how medicines work in children for more than a decade. More>>
Innovative Individualized Pediatric Therapeutic Clinic Addresses Treatment 'Enigmas'
Earlier this year, Children's Mercy launched what may be the first clinic of its kind in the U.S.-the Individualized Pediatric Therapeutics Clinic. More>>
Re-evaluating Adverse Reactions and Improving Drug Safety
Drug allergies can eliminate whole classes of medications for a patient. But what if the patient's response was not truly an allergy, but a different type of adverse reaction or side effect? The clinical and financial implications are enormous. More>>
Translational Research Improves Medication Safety and Efficacy
Children's Mercy is integrating research with treatment by creating translational teams. The program pairs clinicians who identify clinically significant medication-related problems with basic science faculty members who have the expertise necessary to develop solutions to those problems. More>>
Unique Conference Spotlights the use of Genomic Insights to Improve Treatment of Pediatric Patients
More than 200 scientists and clinicians from around the world attended the first Pediatric Pharmacogenomics and Personalized Medicine Conference, hosted by Children's Mercy in April 2010. Experts from academia, government and the private sectors in the U.S., Canada and Japan exchanged knowledge centering on clinical applications, bioethics and development of pediatric personalized medicine programs. More>>
Bioethics at Children's Mercy: Tackling the Tough Questions
When should we use extraordinary means to save a child rather than letting nature take its course? Should we treat otherwise healthy short children with growth hormone to make them taller? How do we draw the line between appropriate uses of stimulant medications and inappropriate ones? What is the best approach to a child born with ambiguous genitalia? More>>